Skip to content
2000
Volume 4, Issue 2
  • ISSN: 2666-7967
  • E-ISSN: 2666-7975

Abstract

This case report presents a case of a 51-year-old male patient who was found to be diabetic after recovering from COVID-19. Case Presentation: The patient was admitted to the COVID care center after testing positive for COVID-19 on November 2020. After spending one week in intensive care and ten days in the isolation ward of the COVID care center, he continued to feel multiple side effects. After fifteen days, he began showing signs of recovery and had no fever or other symptoms of COVID-19. The third SARS-Cov-2 RNA by RT-PCR sample test was also found to be negative. He was shifted to a non- COVID hospital when he became stable. For COVID-19, he was treated with supplementary oxygen therapy by keeping his oxygen level at 5L/min with titrating flow rate SpO2 of more than 90%. The hydroxychloroquine 400 mg orally BD for two days, followed by 200 mg orally BD for four days with a combination of azithromycin 500 mg orally OD for five days, was prescribed to him to treat COVID-19. Conclusion: According to the report "New-onset diabetes in COVID-19," published in the New England Journal of Medicine, there is a bidirectional relationship between COVID-19 and diabetes.

Loading

Article metrics loading...

/content/journals/covid/10.2174/2666796704666230623150612
2023-06-01
2025-09-10
Loading full text...

Full text loading...

/content/journals/covid/10.2174/2666796704666230623150612
Loading

  • Article Type:
    Case Report
Keyword(s): case report; COVID-19; diabetes; hyperglycaemia; pandemic; supplementary
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test